Seeing Is Believing
Healthcare - Sector
KROS is currently covered by 6 analysts with an average price target of $24.68. This is a potential upside of $13.1 (113.13%) from yesterday's end of day stock price of $11.58.
Keros Therapeutics 's activity chart (see below) currently has 76 price targets and 71 ratings on display. The stock rating distribution of KROS is 50% BUY and 50% HOLD.
Analysts average stock forecasts to be materialized ratio is 42.86% with an average time for these price targets to be met of 54.29 days.
Highest price target for KROS is $27, Lowest price target is $16, average price target is $23.
Most recent stock forecast was given by JASON ZEMANSKY from BAML on 28-Nov-2025. First documented stock forecast 04-May-2020.
Currently out of the existing stock ratings of KROS, 5 are a BUY (50%), 5 are a HOLD (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-Jun-2025
$19
$7.7 (68.14%)
$18
3 months 11 days ago
(28-Nov-2025)
2/2 (100%)
$1.52 (8.70%)
91
Buy Since 31-Jul-2023
$27
$15.7 (138.94%)
$23
3 months 27 days ago
(12-Nov-2025)
0/8 (0%)
$9.53 (54.55%)
Hold Since 17-Jan-2025
$16
$4.7 (41.59%)
$15
4 months 5 days ago
(06-Nov-2025)
4/4 (100%)
$-0.17 (-1.05%)
80
Buy Since 26-Jul-2023
$26
$14.7 (130.09%)
$41
9 months 27 days ago
(12-May-2025)
1/6 (16.67%)
$12.26 (89.23%)
215
Buy Since 04-May-2020
$25
$13.7 (121.24%)
$40
10 months 3 days ago
(08-May-2025)
1/14 (7.14%)
$10.98 (78.32%)
113
What is KROS (Keros Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on KROS (Keros Therapeutics )?
Which analyst is the currently most bullish on KROS (Keros Therapeutics )?
Which analyst is the currently most reserved on KROS (Keros Therapeutics )?